Prostate Cancer

Top Story

Ultra-processed foods linked to increased cancer risk

February 14, 2018
FDA News

FDA approves Erleada, first treatment for prostate cancer subtype

February 14, 2018
The FDA approved apalutamide for the treatment of patients with nonmetastatic, castration-resistant prostate cancer. Apalutamide (Erleada, Janssen) inhibits the action…
Meeting News

Addition of enzalutamide to androgen deprivation reduces risk for prostate cancer metastases

February 9, 2018
The addition of enzalutamide to androgen deprivation significantly reduced the risk for metastases or death among men with nonmetastatic castration-resistant prostate…
FDA News

FDA expands Zytiga approval for prostate cancer

February 8, 2018
The FDA expanded the approval of abiraterone acetate to include its use in combination with prednisone for treatment of men with metastatic high-risk, castration…
More Headlines »
CME ABIM MOC

Ace the Case: A 35-Year-Old Man Presents to a Dermatologist with a Brown Pigmented Lesion That Has Been Changing over the past 3 Months

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the diagnosis and management of a 35-year-old man who…
More »
Video

Baseball Hall of Famer Mike Schmidt promotes sun protection, skin cancer awareness

September 28, 2017
More »
Resource Centers
BMT Tandem Meetings

BMT Tandem Meetings

CME ABIM MOC

Ace the Case: 61-Year-Old Male Who Presents to the ER with Worsening Back Pain

There is no commercial support for this activity.

This “Ace the Case” activity will review the diagnosis and management of patients with high-risk multiple…
More »